Exploring the Potential of Eltrombopag: Room for More?

Exploring the Potential of Eltrombopag: Room for More?

Since its introduction in clinical practice, eltrombopag (ELT) has demonstrated efficacy in heterogeneous clinical contexts, encompassing both benign and malignant diseases, thus leading researchers to make a more in-depth study of its mechanism of action. As a result, a growing body of evidence dem...

Full description

Bibliographic Details
Main Authors: Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Maria Rosa Conserva, Immacolata Redavid, Giorgina Specchia, Pellegrino Musto, Francesco Albano
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
eltrombopag
immune thrombocytopenia
severe aplastic anemia
myelodysplastic syndrome
acute myeloid leukemia
poor graft function
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.906036/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.906036/full

Similar Items